API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/union-therapeutics-announces-presentation-of-new-data-on-orismilast-at-the-eadv-congress-2023-301949287.html
https://www.pharmaceutical-technology.com/news/fda-union-oral-orismilast-hs/
https://www.prnewswire.com/news-releases/union-therapeutics-announces-positive-topline-results-from-the-iasos-phase-2b-study-of-oral-orismilast-in-patients-with-moderate-to-severe-psoriasis-301716687.html
https://www.prnewswire.com/news-releases/innovent-and-union-therapeutics-announce-first-subject-dosed-in-a-chinese-clinical-phase-i-study-of-the-novel-pde4-inhibitor-orismilast-ibi353-301692408.html
https://news.cision.com/union-therapeutics/r/union-therapeutics-announces-regulatory-approval-of-treatment-extension-for-the-ongoing-osiris-phase,c3624685